Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10–45. https://doi.org/10.3322/caac.21871.

Article  PubMed  PubMed Central  Google Scholar 

He X, Guan XY, Li Y. Clinical significance of the tumor microenvironment on immune tolerance in gastric cancer. Front Immunol. 2025. https://doi.org/10.3389/fimmu.2025.1532605.

Article  PubMed  PubMed Central  Google Scholar 

He Y, Hong Q, Chen S, Zhou J, Qiu S. Reprogramming tumor-associated macrophages in gastric cancer: a pathway to enhanced immunotherapy. Front Immunol. 2025. https://doi.org/10.3389/fimmu.2025.1558091.

Article  PubMed  PubMed Central  Google Scholar 

Nie SF, Wang CY, Li L, Yang C, Zhu ZM, Fei JD. Tumor recurrence and survival prognosis in patients with advanced gastric cancer after radical resection with radiotherapy and chemotherapy. World J Gastrointest Surg. 2024;16(6):1660. https://doi.org/10.4240/wjgs.v16.i6.1660.

Article  PubMed  PubMed Central  Google Scholar 

Lee HS. Spatial and Temporal tumor heterogeneity in gastric cancer: discordance of predictive biomarkers. J Gastric Cancer. 2025;25(1):192–209. https://doi.org/10.5230/jgc.2025.25.e3.

Article  PubMed  Google Scholar 

Suomivuori CM, Latorraca NR, Wingler LM, Eismann S, King MC, Kleinhenz ALW, et al. Molecular mechanism of biased signaling in a prototypical G protein-coupled receptor. Science. 2020;367(6480):881. https://doi.org/10.1126/science.aaz0326.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cho YY, Kim S, Kim P, Jo MJ, Park SE, Choi Y, et al. G-Protein-Coupled receptor (GPCR) signaling and Pharmacology in metabolism: physiology, mechanisms, and therapeutic potential. Biomolecules. 2025;15(2):103390biom15020291.

Google Scholar 

Hashem S, Dougha A, Tufféry P. Ligand-Induced Biased Activation of GPCRs: Recent Advances and New Directions from In Silico Approaches. Molecules. 2025;30(5)10.3390/molecules30051047.

Ma Y, Patterson B, Zhu L. Biased signaling in gpcrs: structural insights and implications for drug development. Pharmacol Ther. 2025. https://doi.org/10.1016/j.pharmthera.2024.108786.

Article  PubMed  Google Scholar 

Yan H, Zhang JL, Leung KT, Lo KW, Yu J, To KF et al. An Update of G-Protein-Coupled Receptor Signaling and Its Deregulation in Gastric Carcinogenesis. Cancers (Basel). 2023;15(3)10.3390/cancers15030736.

Zhou W, Ouyang J, Li J, Liu F, An T, Cheng L, et al. MRPS17 promotes invasion and metastasis through PI3K/AKT signal pathway and could be potential prognostic marker for gastric cancer. J Cancer. 2021;12(16):4849–61. https://doi.org/10.7150/jca.55719.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang B, Wang L, Lu Y, Liang W, Gao Y, Xi H, et al. GRSF1 promotes tumorigenesis and EMT-mediated metastasis through PI3K/AKT pathway in gastric cancer. Biochem Biophys Res Commun. 2021;55561. https://doi.org/10.1016/j.bbrc.2021.03.121.

Ye M, Xiu LJ, Ji QQ, Zhang YC, Sun YW, Zhao Y, et al. Research progress in targeted therapies for gastric cancer. Int J Clin Pharmacol Ther. 2022;60(12):509–14. https://doi.org/10.5414/cp204250.

Article  CAS  PubMed  Google Scholar 

Lau DK, Collin JP, Mariadason JM. Clinical Developments and Challenges in Treating FGFR2-Driven Gastric Cancer. Biomedicines. 2024;12(5)10.3390/biomedicines12051117.

Yu J, Gimenez LE, Hernandez CC, Wu Y, Wein AH, Han GW, et al. Determination of the melanocortin-4 receptor structure identifies Ca(2+) as a cofactor for ligand binding. Science. 2020;368(6489):428–33. https://doi.org/10.1126/science.aaz8995.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Velazhahan V, Ma N, Pándy-Szekeres G, Kooistra AJ, Lee Y, Gloriam DE, et al. Structure of the class D GPCR Ste2 dimer coupled to two G proteins. Nature. 2021;589(7840):148–53. https://doi.org/10.1038/s41586-020-2994-1.

Article  CAS  PubMed  Google Scholar 

Lopez-Balastegui M, Stepniewski TM, Kogut-Günthel MM, Di Pizio A, Rosenkilde MM, Mao J et al. Relevance of G protein-coupled receptor (GPCR) dynamics for receptor activation, signalling bias and allosteric modulation. Br J Pharmacol. 2024;10.1111/bph.16495.

Calebiro D, Godbole A. Internalization of G-protein-coupled receptors: implication in receptor function, physiology and diseases. Best Pract Res Clin Endocrinol Metab. 2018;32(2):83–91. https://doi.org/10.1016/j.beem.2018.01.004.

Article  CAS  PubMed  Google Scholar 

Duan J, He XH, Li SJ, Xu HE. Cryo-electron microscopy for GPCR research and drug discovery in endocrinology and metabolism. Nat Rev Endocrinol. 2024;20(6):349–65. https://doi.org/10.1038/s41574-024-00957-1.

Article  CAS  PubMed  Google Scholar 

May V, Parsons RL. G Protein-Coupled receptor endosomal signaling and regulation of neuronal excitability and stress responses: signaling options and lessons from the PAC1 receptor. J Cell Physiol. 2017;232(4):698–706. https://doi.org/10.1002/jcp.25615.

Article  CAS  PubMed  Google Scholar 

Fouillen A, Bous J, Granier S, Mouillac B, Sounier R. Bringing GPCR Structural Biology to Medical Applications: Insights from Both V2 Vasopressin and Mu-Opioid Receptors. Membranes (Basel). 2023;13(6)10.3390/membranes13060606.

Cheng L, Xia F, Li Z, Shen C, Yang Z, Hou H, et al. Structure, function and drug discovery of GPCR signaling. Mol Biomed. 2023;4(1). https://doi.org/10.1186/s43556-023-00156-w.

Salom D, Wu A, Liu CC, Palczewski K. The impact of nanobodies on G Protein-Coupled receptor structural biology and their potential as therapeutic agents. Mol Pharmacol. 2024;106(4):155–63. https://doi.org/10.1124/molpharm.124.000974.

Article  CAS  PubMed  Google Scholar 

Wingler LM, Lefkowitz RJ. Conformational basis of G Protein-Coupled receptor signaling versatility. Trends Cell Biol. 2020;30(9)736 − 47. https://doi.org/10.1016/j.tcb.2020.06.002.

Hilger D. The role of structural dynamics in GPCR-mediated signaling. Febs J. 2021;288(8):2461–89. https://doi.org/10.1111/febs.15841.

Article  CAS  PubMed  Google Scholar 

Hilger D, Kumar KK, Hu H, Pedersen MF, O’Brien ES, Giehm L et al. Structural insights into differences in G protein activation by family A and family B GPCRs. Science. 2020;369(6503)10.1126/science.aba3373.

Szwabowski GL, Baker DL, Parrill AL. Application of computational methods for class A GPCR ligand discovery. J Mol Graph Model. 2023. https://doi.org/10.1016/j.jmgm.2023.108434.

Article  PubMed  Google Scholar 

Alhosaini K, Azhar A, Alonazi A, Al-Zoghaibi F, GPCRs. The most promiscuous druggable receptor of the mankind. Saudi Pharm J. 2021;29(6):539–51. https://doi.org/10.1016/j.jsps.2021.04.015.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wootten D, Miller LJ. Structural basis for allosteric modulation of class B G Protein-Coupled receptors. Annu Rev Pharmacol Toxicol. 2020. https://doi.org/10.1146/annurev-pharmtox-010919-023301. 6089– 107.

Article  PubMed  Google Scholar 

Ellaithy A, Gonzalez-Maeso J, Logothetis DA, Levitz J. Structural and biophysical mechanisms of class C G Protein-Coupled receptor function. Trends Biochem Sci. 2020;45(12):1049–64. https://doi.org/10.1016/j.tibs.2020.07.008.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Turku A, Schihada H, Kozielewicz P, Bowin CF, Schulte G. Residue 6.43 defines receptor function in class F GPCRs. Nat Commun. 2021;12(1). https://doi.org/10.1038/s41467-021-24004-z.

Sun ZB, Yu SF, Wang CL, Wang L. cAMP signalling pathway in biocontrol Fungi. Curr Issues Mol Biol. 2022;44(6):2622. https://doi.org/10.3390/cimb44060179.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Conflitti P, Lyman E, Sansom MSP, Hildebrand PW, Gutiérrez-de-Terán H, Carloni P et al. Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery. Nat Rev Drug Discov. 2025;10.1038/s41573-024-01083-3.

Yang Y, Chen M, Qiu Y, Li X, Huang Y, Zhang W. The apelin/aplnr system modulates tumor immune response by reshaping the tumor microenvironment. Gene. 2022. https://doi.org/10.1016/j.gene.2022.146564.

Article  PubMed  PubMed Central  Google Scholar 

Lovászi M, Branco Haas C, Antonioli L, Pacher P, Haskó G. The role of P2Y receptors in regulating immunity and metabolism. Biochem Pharmacol. 2021. https://doi.org/10.1016/j.bcp.2021.114419.

Article  PubMed  Google Scholar 

Ma N, Xu E, Luo Q, Song G. Rac1: A Regulator of Cell Migration and a Potential Target for Cancer Therapy. Molecules. 2023;28(7)10.3390/molecules28072976.

Wang J, Ding N, Chen C, Gu S, Liu J, Wang Y, et al. Adropin: a key player in immune cell homeostasis and regulation of inflammation in several diseases. Front Immunol. 2025. https://doi.org/10.3389/fimmu.2025.1482308.

Article  PubMed  PubMed Central  Google Scholar 

Li L, An Z, Lin C, Xu Q, Tang C. An update on regulation and function of G protein-coupled receptors in cancer: A promising strategy for cancer therapy. Biochim Biophys Acta Rev Cancer. 2025;1880(2). https://doi.org/10.1016/j.bbcan.2025.189266.

Park SG, Lee JY, Seo H, Hwang SS, Lee CK, Lee GR. Modulation of immune responses by metabolic reprogramming: the key role of immunometabolism. Immune Netw. 2025;25(1):e15. https://doi.org/10.4110/in.2025.25.e15.

Article